Skip to main content
When to Worry and When Not To
The Mind's Companion · BML-04.01

When to Worry and When Not To

Series 04: The Mind's Companion

In a Hurry? Read the executive summary.

Beverly Okafor and Janet Reiss have been meeting for lunch on Tuesdays for nine years. They are 71 and 70, both retired, both sharp in ways they do not give themselves credit for. Today at the Italian place on Grant Street, they are comparing memory stories the way they always do. Beverly forgot where she parked at the grocery store last Tuesday. Janet forgot her dentist appointment entirely. They laugh about it. They have been laughing about it for two years.

Beverly notices something she cannot name. Janet’s laugh arrives a fraction of a second later than it used to. Not a delay anyone else would catch. Beverly catches it because she has been listening to that laugh since they were both 62 and walking the same block in the mornings. She does not know what to do with the observation. She does not know whether it means something or whether she is manufacturing fear out of friendship and too many magazine articles about Alzheimer’s.

The Normal Side of the Line
#

The brain at 70 is not the brain at 30, and nobody promises it should be. Processing speed declines across adulthood, measurably, in everyone. The word that was on the tip of your tongue takes longer to arrive. Learning a new phone takes more repetitions than it used to. You forget why you walked into the kitchen, but when you walk back to the living room, you remember.

These changes are real. They are also normal. The neurons are intact. The networks that connect them are intact. The highway is the same highway. The speed limit has come down. That is age-related cognitive change, and it does not indicate dementia. It indicates a brain that has been running for seven decades and has slowed down in predictable, documented ways that do not involve the death of brain cells.

The things most people worry about are, in most cases, normal. You lose your car in the parking lot because you were thinking about the grocery list when you walked inside. You forget a name you have known for twenty years and remember it at 3 AM. You read a paragraph and realize at the bottom that you absorbed none of it. All of these are consistent with healthy aging. All of them are also consistent with talking yourself into a panic at 2 AM.

The Other Side of the Line
#

The Alzheimer’s Association publishes ten warning signs. They are useful because they are specific, and the specificity matters more than the number. Forgetting where you put your keys is normal. Forgetting what keys are for is a warning sign. Getting lost on a new road is normal. Getting lost on the route you have driven for thirty years is a warning sign.

The other signs are equally specific. Difficulty completing familiar tasks, not new ones. Confusion about what day it is, not momentary but persistent. Withdrawal from activities you used to enjoy, not because you chose something else but because the activity has become too difficult to follow. New problems with words in speaking or writing, not the occasional search for the right term but a pattern of substitution and circumlocution that changes how your sentences sound. Changes in judgment about money, hygiene, or social situations that represent a departure from how you have operated for decades.

No single incident on either list constitutes a diagnosis. The distinction that matters is between a moment and a pattern. The pattern unfolds over months, not over one Tuesday lunch.

The Mechanism Beneath the Difference
#

The reason the warning signs feel similar to normal aging complaints is that they sometimes produce the same visible result. You forgot an appointment. That could be either side of the line. The difference is what is happening underneath.

Age-related cognitive change is a slowdown in healthy tissue. The neurons are alive. The connections are intact. The processing takes longer, and the retrieval sometimes fails, but the hardware is fundamentally sound. Early dementia is different. Neurons are dying. Synaptic connections are being severed. The tissue itself is being destroyed by protein accumulation, vascular damage, or inflammation, depending on the type of dementia. The distinction is not about how severe the symptom feels to you. It is about what is causing it. You cannot tell from the outside. Only a physician can.

What Kind of Doctor, and What to Expect
#

The right first call is your primary care physician. Not a neurologist, not a specialist. Your PCP. If she has any reason to be concerned, she will refer you. If she does not, she will tell you why, and the conversation alone is worth the appointment.

What happens at a cognitive assessment visit: a conversation about what you have noticed and when. A screening test, usually the MoCA, which takes about ten minutes and involves drawing a clock, remembering a short list of words, naming animals, and a few other tasks designed to test specific cognitive domains. A physical exam looking for the causes of cognitive complaints that are completely reversible: thyroid dysfunction, vitamin B12 deficiency, medication side effects, depression. These treatable causes produce symptoms that look like early dementia and are not dementia at all.

If the MoCA or the conversation raises a concern, referral to neurology or geriatrics is the next step. A full neurological workup involves neuropsychological testing (two to three hours of structured assessment), brain imaging (MRI to look at structure, sometimes PET to look at amyloid or tau protein accumulation), and in some cases blood or cerebrospinal fluid biomarker testing. The workup is thorough because the stakes of the diagnosis are high. A neurologist will not tell you that you have Alzheimer’s based on a ten-minute screen. She will tell you after the work has been done to be sure.

The Emotional Experience of Asking
#

The hardest part is not the appointment. The hardest part is making the appointment. The fear that asking the question confirms the answer. The family member who wants to say something and the person who does not want to hear it. The patient who changes the subject when the physician asks about memory, and the physician who lets the subject change because she has eleven minutes left and three more patients.

The fear is understandable. It is also wrong about one thing. Asking the question does not change the answer. If the answer is normal aging, the appointment produces relief and a baseline for future comparison. If the answer is something else, the appointment produces information at the moment when that information has its maximum value. Early-stage cognitive impairment is the period of greatest agency. Plans can be made. Preferences can be stated. Documents can be prepared. Clinical trials, some available only to early-stage patients, can be considered. The window of action is widest at the beginning. It does not open wider by waiting.

Beverly’s Observation
#

Beverly should not diagnose her friend. A fraction of a second’s delay in a laugh is not a clinical sign. It is one observation, on one Tuesday, from a person who loves her friend and has read enough to be worried. Warning signs require a pattern that unfolds over time, not a single moment at lunch.

What Beverly can do is pay attention without catastrophizing. Notice whether the pattern repeats. Notice whether Janet starts telling the same story twice in the same lunch, or stops following the conversation the way she used to, or cancels lunches with reasons that sound thin. None of these is a diagnosis. A cluster of them, over months, is a reason to have a careful and honest conversation with Janet about seeing her doctor. For the full account of what the period before a cognitive diagnosis looks and feels like, see Before the Diagnosis on Blue Gray Matters.

Beverly does not need to say the word Alzheimer’s at lunch. She needs to pay attention, know what the warning signs actually are, and know the difference between a concern worth raising now and one worth watching over time. Today is a watching day. It may stay a watching day. That would be a good outcome.

The Window That Exists Early
#

If it is dementia, the window of maximum agency is not next year. It is now. The specific value of early detection is not comfort. It is time.

Time to update legal documents while you can still sign them with full capacity. Time to tell your family what you want your care to look like. Time to decide who makes medical decisions when you cannot. Time to participate in clinical trials that require early-stage enrollment. Time to write down what you want people to know about you before the disease changes how you present yourself to the world. Time to make the decisions that the disease will otherwise make for you.

That is not a reason to be afraid of asking. It is the reason to ask.

Beverly and Janet finish lunch. Janet picks up the check. She calculates the tip correctly, the way she always has. Beverly watches her do it. The math is fine. The laugh is still a fraction of a second late. Beverly does not know what either of those things means. She knows where to find out.

How this article connects to others in Blue Mirror.

BML-04.02 introduces the longitudinal cognitive monitoring that complements the clinical screening described here, catching changes the MoCA structurally cannot detect.
BML-04.04 addresses what happens when personal AI monitoring reveals a cognitive trend change, the moment that clinical screening from this article would eventually reach but later.
BML-04.C1 provides the practical playbook for the person who has moved from the worry described here to a confirmed diagnosis.
BGM-2A covers the emotional and clinical landscape of the pre-diagnosis period, providing the evidentiary foundation for the screening and decision-making framework presented here.
BGM-2B provides the epidemiological context for Alzheimer's incidence and clinical trajectory that informs the warning signs distinguished in this article.

Sources cited in this article.

  1. Alzheimer's Association. "10 Early Signs and Symptoms of Alzheimer's." Alzheimer's Association, 2024.
  2. Nasreddine, Ziad S., et al. "The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool for Mild Cognitive Impairment." Journal of the American Geriatrics Society, vol. 53, no. 4, 2005, pp. 695-699.
  3. Salthouse, Timothy A. "When Does Age-Related Cognitive Decline Begin?" Neurobiology of Aging, vol. 30, no. 4, 2009, pp. 507-514.
  4. Jessen, Frank, et al. "A Conceptual Framework for Research on Subjective Cognitive Decline in Preclinical Alzheimer's Disease." Alzheimer's & Dementia, vol. 10, no. 6, 2014, pp. 844-852.
  5. Petersen, Ronald C. "Mild Cognitive Impairment." New England Journal of Medicine, vol. 364, no. 23, 2011, pp. 2227-2234.